The bio-services sector, which is currently valued at USD 5-6 billion, is set to increase to USD 50 billion soon, said a CII statement quoting Subburaj as saying.
He was speaking at a round-table at Global Exhibition on Services (GES).
Early this month, Fertiliser Minister Ananth Kumar had said that government is aiming to increase the size of domestic medical devices sector to USD 50 billion by taking of a slew of measures.
Speaking at the event, Department of Commerce Joint Secretary Sudhanshu Pandey said that a new policy on clinical trials coming in place in three months' time.
"That is going to change with the new policy on clinical trials coming in place in three months' time," Pandey said.
Subburaj said that the number of applications being filed for clinical trials in India has come down from 500 to 25 in the past three years.
"We have all the hardware but software is missing. That is the reason why we are lagging behind. In the US more than 30,000 clinical trials take place every year. Israel does 4,900 clinical trials every year," he said.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
